{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:01Z","timestamp":1707524581970},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,2]]},"DOI":"10.7759\/cureus.22768","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:05:03Z","timestamp":1646233503000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Pneumocystis jirovecii Pneumonia Due to Absolute Lymphopenia"],"prefix":"10.7759","author":[{"given":"Eric","family":"Hilker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin M","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodger","family":"Wilhite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zach","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2014.01.007","article-title":"Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients","volume":"44","author":"Roux A","year":"2014","unstructured":"Roux A, Gonzalez F, Roux M, et al.. Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients. Med Mal Infect. 2014, 44:185-98. 10.1016\/j.medmal.2014.01.007","journal-title":"Med Mal Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.05.558","article-title":"Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases","volume":"158","author":"Ghembaza A","year":"2020","unstructured":"Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D. Risk factors and prevention of Pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases. Chest. 2020, 158:2323-32. 10.1016\/j.chest.2020.05.558","journal-title":"Chest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-005-0443-5","article-title":"Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature","volume":"16","author":"Kaneko Y","year":"2006","unstructured":"Kaneko Y, Suwa A, Ikeda Y, Hirakata M. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Mod Rheumatol. 2006, 16:36-8. 10.1007\/s10165-005-0443-5","journal-title":"Mod Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel L","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, et al.. 2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021, 73:924-39. 10.1002\/acr.24596","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05660-4","article-title":"Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study","volume":"40","author":"Hsu HC","year":"2021","unstructured":"Hsu HC, Chang YS, Hou TY, et al.. Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study. Clin Rheumatol. 2021, 40:3755-63. 10.1007\/s10067-021-05660-4","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199905000-00004","article-title":"Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections","volume":"11","author":"Singer NG","year":"1999","unstructured":"Singer NG, McCune WJ. Prevention of infectious complications in rheumatic disease patients: immunization, Pneumocystis carinii prophylaxis, and screening for latent infections. Curr Opin Rheumatol. 1999, 11:173-8. 10.1097\/00002281-199905000-00004","journal-title":"Curr Opin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward MM","year":"1999","unstructured":"Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999, 42:780-9. 10.1002\/1529-0131(199904)42:4&lt;780::AID-ANR23&gt;3.0.CO;2-M","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0664-6","article-title":"Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented?","volume":"19","author":"Wolfe RM","year":"2017","unstructured":"Wolfe RM, Peacock JE Jr. Pneumocystis pneumonia and the rheumatologist: which patients are at risk and how can PCP be prevented?. Curr Rheumatol Rep. 2017, 19:35. 10.1007\/s11926-017-0664-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-008-0037-0","article-title":"Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy","volume":"18","author":"Mori S","year":"2008","unstructured":"Mori S, Cho I, Ichiyasu H, Sugimoto M. Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy. Mod Rheumatol. 2008, 18:240-6. 10.1007\/s10165-008-0037-0","journal-title":"Mod Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4137\/CCRPM.S23286","article-title":"Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations","volume":"9","author":"Mori S","year":"2015","unstructured":"Mori S, Sugimoto M. Pneumocystis jirovecii pneumonia in rheumatoid arthritis patients: risks and prophylaxis recommendations. Clin Med Insights Circ Respir Pulm Med. 2015, 9:29-40. 10.4137\/CCRPM.S23286","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"ref11","article-title":"Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience","volume":"35","author":"Mecoli CA","year":"2017","unstructured":"Mecoli CA, Saylor D, Gelber AC, Christopher-Stine L. Pneumocystis jiroveci pneumonia in rheumatic disease: a 20-year single-centre experience. Clin Exp Rheumatol. 2017, 35:671-3.","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.12.052","article-title":"Incidence of pneumocystosis among patients exposed to immunosuppression","volume":"80","author":"Rekhtman S","year":"2019","unstructured":"Rekhtman S, Strunk A, Garg A. Incidence of pneumocystosis among patients exposed to immunosuppression. J Am Acad Dermatol. 2019, 80:1602-7. 10.1016\/j.jaad.2018.12.052","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.7.594","article-title":"Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study","volume":"58","author":"Maskell NA","year":"2003","unstructured":"Maskell NA, Waine DJ, Lindley A, Pepperell JC, Wakefield AE, Miller RF, Davies RJ. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax. 2003, 58:594-7. 10.1136\/thorax.58.7.594","journal-title":"Thorax"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0196-0644(98)70008-3","article-title":"Absolute lymphocyte count as a predictor of CD4 count","volume":"32","author":"Shapiro NI","year":"1998","unstructured":"Shapiro NI, Karras DJ, Leech SH, Heilpern KL. Absolute lymphocyte count as a predictor of CD4 count. Ann Emerg Med. 1998, 32:323-8. 10.1016\/s0196-0644(98)70008-3","journal-title":"Ann Emerg Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.02.010","article-title":"Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping","volume":"57","author":"Li Y","year":"2017","unstructured":"Li Y, Ghannoum M, Deng C, Gao Y, Zhu H, Yu X, Lavergne V. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping. Int J Infect Dis. 2017, 57:108-15. 10.1016\/j.ijid.2017.02.010","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1093\/milmed\/161.1.58","article-title":"Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia","volume":"161","author":"Krebs S","year":"1996","unstructured":"Krebs S, Gibbons RB. Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. Mil Med. 1996, 161:58-60.","journal-title":"Mil Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600219","article-title":"Methotrexate and nonsteroidal antiinflammatory drug interactions","volume":"26","author":"Frenia ML","year":"1992","unstructured":"Frenia ML, Long KS. Methotrexate and nonsteroidal antiinflammatory drug interactions. Ann Pharmacother. 1992, 26:234-7. 10.1177\/106002809202600219","journal-title":"Ann Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green H","year":"2007","unstructured":"Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc. 2007, 82:1052-9. 10.4065\/82.9.1052","journal-title":"Mayo Clin Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/89488-acute-pneumocystis-jirovecii-pneumonia-due-to-absolute-lymphopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:48Z","timestamp":1707507588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/89488-acute-pneumocystis-jirovecii-pneumonia-due-to-absolute-lymphopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.22768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}